Herasight is a startup based in the United States, 1 tracked investor.
Based in the United States, Herasight is a startup. Brouky records 1 investor associated with the company.
Herasight develops advanced genetic screening tools for embryos, using whole genome technologies and polygenic risk scoring to help prospective parents assess and reduce disease risks during IVF.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.